JVS Founder Plans International Expansion for IdPods E-Cigarette

Business by 2FIRSTS.ai
Dec.12.2023
JVS Founder Plans International Expansion for IdPods E-Cigarette
JVS Group, the Indonesian company behind e-cigarette brand IdPods, plans to expand internationally by year-end.

According to a report by Indonesian news outlet Viva on December 10th, Budiyanto Imam Suyanto, founder of the JVS Group in Indonesia, plans to expand the international market for their e-cigarette product, IdPods, by the end of this year. This move comes after their recent launch of a "beverage series" e-cigarette, which offers three unique flavors.

 

We have just signed contracts with Vietnam, Malaysia, and Russia. Starting this month, we will begin exporting IdPods, not only to Indonesia but also internationally," stated JVS. "We aim for this beverage line to bring innovation to the e-cigarette industry.

 

In addition, IdPods is also planning to launch the "idPreneur" support program, aimed at assisting small and micro enterprises as well as individuals who are interested in the e-cigarette industry. This initiative focuses on developing high-quality products that cater to the demands of e-cigarette consumers, with the aim of significantly increasing profit opportunities and providing limitless additional income.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
The US Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Imperial Tobacco’s blu® Disposable Classic Tobacco 2.4% e-cigarette, prohibiting its sale and distribution in the United States. FDA’s review found that the company’s Premarket Tobacco Product Application (PMTA) did not provide sufficient evidence to demonstrate that the product could help smokers fully switch to e-cigarettes or significantly reduce cigarette consumption. Instead, existing evidence suggested
Aug.20 by 2FIRSTS.ai
2Firsts Interview | Sneak Peek: Westfallenhallen’s Sabine Loos Reveals What Visitors Can Expect at InterTabac 2025
2Firsts Interview | Sneak Peek: Westfallenhallen’s Sabine Loos Reveals What Visitors Can Expect at InterTabac 2025
As an official media partner of InterTabac, 2Firsts spoke exclusively with Sabine Loos, Managing Director of Westfalenhallen Unternehmensgruppe, to preview the 45th edition of the event. This year’s InterTabac and InterSupply will feature 11 halls, over 800 exhibitors, dozens of forums, and major product debuts. The interview explores trends in NGPs, oral nicotine, hybrid formats, and global regulatory topics—offering a comprehensive look into innovation and industry dialogue.
Aug.06
2Firsts Interviews ASDF on Malaysia’s Vape Ad Ban, Total Prohibition Plans, and What’s Next
2Firsts Interviews ASDF on Malaysia’s Vape Ad Ban, Total Prohibition Plans, and What’s Next
Malaysia’s Vape Market in Turmoil.Since the implementation of Act 852, Malaysia’s e-cigarette sector has been undergoing intense upheaval. From stricter compliance inspections and a full advertising ban to a proposal for a complete sales prohibition, a regulatory storm is reshaping the industry landscape.2Firsts talks with leading local brand ASDF to learn how it is responding to challenges and laying out a compliance roadmap in the current policy environment.
Aug.14
Product | UK MHRA Lists Multiple Low-Nicotine Sweet-Flavored SKUs from AL FAKHER; VOZOL and VOOPOO Roll Out New Open-System Devices
Product | UK MHRA Lists Multiple Low-Nicotine Sweet-Flavored SKUs from AL FAKHER; VOZOL and VOOPOO Roll Out New Open-System Devices
The UK MHRA database shows a surge of new SKU listings from brands like ELFBAR and SKE in early July, featuring high-capacity devices and low-nicotine sweet-flavored products. Amid the looming disposable vape ban, compliant products such as open-system devices have become the focus of these filings.
Jul.09 by 2FIRSTS.ai
Australian Government-Funded Vaping Education Program Featured in The Lancet: Student Vaping Rates Drop by 65%
Australian Government-Funded Vaping Education Program Featured in The Lancet: Student Vaping Rates Drop by 65%
Australia’s “OurFutures” vaping education program cut student vaping rates by 65% after 12 months, according to a trial of 5,000 students across 40 schools. Published in The Lancet, it is the first proven effective school-based e-health intervention in Australia. The program will be expanded through 2028, with long-term data expected in 2026.
Jul.29 by 2FIRSTS.ai
Thai Police Raid Illegal Vape Operation, Seize Over 20,000 Products
Thai Police Raid Illegal Vape Operation, Seize Over 20,000 Products
On July 29, Thai police raided an apartment in Bangkok and seized over 20,000 illegal vape components, including more than 1,000 pods and a large quantity of e-liquid.
Aug.01 by 2FIRSTS.ai